Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study

Araz, M.Karaagac, M.Korkmaz, L.Koral, L.Inci, F.Beypinar, I.Uysal, M.2024-02-232024-02-2320180923-75341569-8041https://hdl.handle.net/20.500.12452/1729843rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational studyConference Object29636636Q1WOS:000459277304157Q1